Curcumin-supplemented yoghurt improves physiological and biochemical markers of experimental diabetes

British Journal of Nutrition

Volumn 108, Issue 3, 2012, Pages 440-448

  Gutierres, Vânia O ^a   Pinheiro, Clara M ^a   Assis, Renata P ^a   Vendramini, Regina C ^a   Pepato, Maria T ^a   Brunetti, Iguatemy L ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Body weight; Functional food; Glycaemia; Proteinuria

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CURCUMIN; GLUCOSE; GLYCOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; UREA; YOGHURT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC DIET; DIET SUPPLEMENTATION; DISEASE MARKER; ENZYME ACTIVITY; GLUCOSE URINE LEVEL; GLYCOGEN LIVER LEVEL; LONG TERM CARE; MALE; NONHUMAN; PROTEINURIA; RAT; STREPTOZOCIN DIABETES; TISSUE LEVEL; TREATMENT OUTCOME; URINE VOLUME;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHOLESTEROL; CURCUMIN; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; EATING; GLYCOSURIA; MALE; RATS; RATS, WISTAR; UREA; YOGURT;

EID: 84865248403     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511005769     Document Type: Article

References (48)

1. Sacks DB (2006) Carbohydrates. In Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 4th ed., pp. 837-867 [CA Burtis, ER Ashwood and DE Bruns, editors]. St Louis, MO: Elsevier Saunders.
2. Shaw JE, Sicree RA & Zimment PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87, 4-14.
3. Siró I, Kálpona E, Kálpona B, et al. (2008) Functional food. Product development, marketing and consumer acceptance - a review. Appetite 51, 456-467.
4. He M, Yang H, Han JH, et al. (2005) Effects of yoghurt supplementation on the growth of preschool children in Beijing suburbs. Biomed Environ Sci 18, 192-197. (Pubitemid 41127547)
5. Apostolidis E, Knon YI & Shetty K (2006) Potential of select yogurts for diabetes and hypertension management. J Food Biochem 30, 699-717. (Pubitemid 44770786)
6. Epstein J, Sanderson IAN & MacDonald TT (2009) Curcumin as a the therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 103, 1545-1557.
7. Nisshiyama T, Mae T & Kishida H (2005) Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress and increase in blood glucose level in type 2 diabetic KK-Ay mice. J Agric Food Chem 53, 959-963. (Pubitemid 40270383)
8. Hussein HK & Abu-Zinadah OA (2010) Antioxidant effect of curcumin extracts in induced diabetic wister rats. Int J Zool Res 6, 266-276.
9. Babu P & Srinivasan K (1997) Hypolipidemic action of curcumin, the active principle of turmeric Curcuma longa in streptozotocin induced diabetic rats. Mol Cell Biochem 166, 169-175. (Pubitemid 27085099)
10. Asai A & Miyazawa T (2001) Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr 131, 2932-2935. (Pubitemid 33063126)
11. Seo KII, Choi MS, Jung UJ, et al. (2008) Effect of curcumin supplementation on blood glucose, plasma insulin, and homeostasis related enzyme activities in diabetic db/db mice. Mol Nutr Food Res 52, 995-1004.
12. Suryanarayana P, Saraswat M, Mrudula T, et al. (2005) Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophtalmol Vis Sci 6, 2092-2099.
13. Sharma S, Kulkarni S & Chopra K (2006) Curcumin the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 33, 940-945. (Pubitemid 44427317)
14. Babu PS & Srinivasan K (1998) Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats. Mol Cell Biochem 181, 87-96. (Pubitemid 28127781)
15. Dutta S, Padhye S, Priyadarsini KI, et al. (2005) Antioxidant and antiproliferative activity of curcumin semicarbazone. Bioorg Med Chem Lett 15, 2738-2744. (Pubitemid 40732210)
16. Goel A, Kunnumakkara AB & Aggarwal B (2008) Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 75, 787-809.
17. Shankar T, Shantha N, Ramesh H, et al. (1980) Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guineapigs & monkeys. Indian J Exp Biol 18, 73-75. (Pubitemid 10143537)
18. Lao C, Ruffin M, Normolle D, et al. (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6, 10-15.
19. Anand P, Kunnumakkara AB, Newman RA, et al. (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4, 807-818.
20. Shaik J, Ankola DD, Beniwal V, et al. (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37, 223-230.
21. Chen C, Johnston TD, Jeon H, et al. (2009) An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. Int J Pharm 36, 133-139.
22. Maiti K, Mukherjee K, Gantait A, et al. (2007) Curcumin- phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 330, 155-163. (Pubitemid 46097368)
23. Shoba G, Joy D, Joseph T, et al. (1998) Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64, 353-356. (Pubitemid 28234275)
24. Trinder P (1969) Determination of glucose in blood using glucose oxidase with alternative oxygen acceptor. Ann Clin Biochem 6, 24-27.
25. The Committee on Enzyme of Scandinavian Society for Clinical Chemistry and Clinical Physiology (1974) Recommended methods for the determination of four enzymes in blood. Scand J Clin Lab Invest 33, 291-306.
26. Tietz NW, Rinker AD & Shaw LM (1983) IFCC methods for the measurement of catalytic concentraction of enzymes. Part 5. IFCC method for alkaline phosphatase (orthphosphoric- monoester phosphohydrolase, alkaline optimum, EC 3.1.3.1). J Clin Chem Clin Biochem 21, 731-748. (Pubitemid 14208514)
27. Rifai N & Warnick GR (2006) Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 4th ed., pp. 903-981 [CA Burtis, ER Ashwood and DE Bruns, editors]. St Louis, MO: Elsevier Saunders.
28. Sugiuchi H & Okabe H (2002) Development of homogeneous assay for HDL-C in serum. Risho Byori 50, 226-233.
29. Bradford MM (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72, 248-254.
30. Bergmeyer HU (1985) Methods of Enzymatic Analysis, 3rd ed., pp. 449-453 [HU Bergmeyer, J Bergmeyer and M Grassl, editors]. Deerfield Beach, FL: Verlag Chemie.
31. Dubowski KM (1962) An o-toluidine method for body fluid glucose determination. Clin Chem 8, 215-235.
32. Vies VD (1953) Two methods for the determination of glycogen in liver. Pharmacol Res 57, 410-416.
33. Al-Awwadi N, Azay J, Poucheret P, et al. (2004) Antidiabetic activity of red wine polyphenolic extract, ethanol, or both in streptozotocin-treated rats. J Agric Food Chem 52, 1008-1016.
34. Mori DM, Baviera AM, Ramalho LTO, et al. (2003) Temporal response pattern of biochemical analytes in experimental diabetes. Biotechnol Appl Biochem 38, 183-191. (Pubitemid 37289834)
35. Sarkhail P, Rahmaipour S, Fadyevatan S, et al. (2007) Antidiabetic effect of Phlomis anisodonta: effects on hepatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Pharmacol Res 56, 261-266. (Pubitemid 47321210)
36. Sekiya M, Yahagi N, Tamura Y, et al. (2009) Hormonesensitive lipase deficiency suppresses insulin secretion from pancreatic islet of Lep ob/ob mice. Biochem Biophys Res Commun 387, 511-515.
37. Zelent D, Najafi H, Odili S, et al. (2005) Glucokinase and glucose homeostasis: proven concepts and new ideas. Biochem Soc Trans 33, 306-310. (Pubitemid 40313829)
38. Pari L & Murugan P (2005) Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. J Basic Clin Physiol Pharmacol 4, 257-274. (Pubitemid 43089170)
39. Narayanasamy A, Namasivayam N & Radha K (2003) Effect of tumeric on the enzymes of glucose metabolism in diabetic rats. J Herbs Spices Med Plants 10, 75-84. (Pubitemid 36120253)
40. Arun N & Nalini N (2002) Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plants Foods Hum Nutr 1, 41-52. (Pubitemid 34128408)
41. Fujiwara H, Hosokawa M, Zhou X, et al. (2008) Curcumin inhibits glucose production in isolated mice hepatocytes. Diabetes Res Clin Pract 80, 185-191.
42. Mithieux G, Guignotl G, Bordet JC, et al. (2002) Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet. Diabetes 51, 139-143. (Pubitemid 34517990)
43. Kang C & Kim E (2010) Synergistic effect of curcumin and insulin on muscle cell glucose metabolism. Food Chem Toxicol 48, 2366-2373.
44. Martin A, Sven-Olof O, Marja RT, et al. (2006) Diabetic dyslipidaemia. Curr Opin Lipidol 17, 238-246.
45. Soni Kb & Kuttan R (1992) Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 36, 273-275. (Pubitemid 23031285)
46. Na LX, Zhang YL, Li Y, et al. (2011) Curcumin improves insulin resistance in skeletal muscle of rats. Nutr Metab Cardiovasc Dis 21, 526-533.
47. Baum L, Cheung SK, Mok VC, et al. (2007) Curcumin effects on blood lipid profile in 6-month human study. Pharmacol Res 56, 509-514. (Pubitemid 350137772)
48. Babu PS & Srinivasan K (1995) Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Mol Cell Biochem 1, 13-21.